Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference44 articles.
1. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit.;LE Huang;J Biol Chem,1996
2. Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction.;E Minet;FEBS Lett,1999
3. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.;NJ Mabjeesh;Cancer Res,2002
4. Angiogenesis in cancer, vascular, rheumatoid and other disease.;J Falkman;Nat Med,1995
5. The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase.;HJ Ochel;Mol Genet Metab,1999
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibition of the HSP90 homodimerization and HSP90-HIF1α interactions by employing small molecules at C-terminal ATP binding site of HSP90;2024-06-03
2. Understanding the Significance of Hypoxia-Inducible Factors (HIFs) in Glioblastoma: A Systematic Review;Cancers;2024-05-30
3. Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells;Revista Brasileira de Farmacognosia;2024-03-02
4. New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells;Biomedicine & Pharmacotherapy;2023-07
5. Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects;OncoTargets and Therapy;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3